| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.004 |